Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Purpose
This is a Phase 3 global, multicenter, 52-week, open-label extension (OLE) rollover study for subjects completing study CN012-0026, CN012-0027 or CN012-0056. Subjects (randomized or non-randomized) who complete the 38-week CN012-0026 study, 14-week CN012-0027 study or 14-week CN012-0056 study will be eligible to enroll in CN012-0028. The primary objective of the study is to assess the long-term safety and tolerability of KarXT in subjects with psychosis associated with Alzheimer's Disease.
Condition
- Psychosis Associated With Alzheimer's Disease
Eligibility
- Eligible Ages
- Between 55 Years and 90 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Must have completed study CN012-0026, CN012-0027 or CN012-0056. - Subject was aged 55 to 90 years, inclusive, at the time of enrollment into the parent CN012-0026, CN012-0027 or CN012-0056 study. - Can understand the nature of the study and protocol requirements and provide a signed informed consent or, if deemed not competent to provide informed consent, the subject's legally acceptable representative must provide informed consent, and the subject must provide informed assent before any study assessments are performed. - At entry into this study, or any time during the study, if a subject needs to relocate from home or residential assisted-living facility to a nursing home facility, the Sponsor/Medical Monitor must approve the subject's participation in the study. - Have an identified or proxy caregiver (spends approximately 10 hours/week with the subject).
Exclusion Criteria
- Significant or severe medical conditions that, in the opinion of the Investigator, could jeopardize the safety of the subject, ability to complete or comply with the study procedures or validity of the study results. - Clinically significant abnormalities, including any finding(s) from the ECG, laboratory tests, physical examination, or vital signs, at the EOT visit of Study CN012-0026, CN012-0027 or CN012-0056 that the Investigator, in consultation with the Medical Monitor, are considered to jeopardize the safety of the subject. - Subjects participating in another investigational drug or device study or planning on participating in another clinical study during the duration of CN012-0028. - Other protocol-defined Inclusion/Exclusion criteria apply.
Study Design
- Phase
- Phase 3
- Study Type
- Interventional
- Allocation
- N/A
- Intervention Model
- Single Group Assignment
- Primary Purpose
- Treatment
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental KarXT |
Xanomeline and Trospium Chloride Capsules |
|
Recruiting Locations
Anaheim 5323810, California 5332921 92805-5854
Steven Macina, Site 1104
714-999-6688
Los Angeles 5368361, California 5332921 90033-5313
Lon Schneider, Site 1226
323-442-3715
Pasadena 5381396, California 5332921 91106
M. Lorraine Purino, Site 1043
626-250-2070
Sherman Oaks 5395244, California 5332921 91403-2131
MARIA SELIVERSTOV, Site 1103
818-990-2671
Farmington 4834272, Connecticut 4831725 06030
Neha Jain, Site 1222
860-790-7354
Clermont 4151352, Florida 4155751 34711-5933
Christopher Galloway, Site 1048
321-500-5252
Cutler Bay 6332309, Florida 4155751 33189-1230
Suez Oramas Mingo, Site 1138
305-424-8696
Daytona Beach 4152872, Florida 4155751 32117-5532
David Billmeier, Site 1023
386-278-8000
Doral 4153471, Florida 4155751 33122-1620
Lucinda Cuervo-Ramos, Site 1164
305-888-0410
Doral 4153471, Florida 4155751 33172-2638
Beatriz Triana, Site 1045
786-741-2287
Hialeah 4158476, Florida 4155751 33012-3158
Amnerys Garcia, Site 1155
305-246-0873
Hialeah 4158476, Florida 4155751 33012-3618
Manuel Fernandez, Site 1107
305-828-3555
Hialeah 4158476, Florida 4155751 33012-4648
Jorge Betancourt, Site 1120
305-456-7782
Hialeah 4158476, Florida 4155751 33012
Frank Carlos Alvarez Li, Site 1052
786-334-6675
Hialeah 4158476, Florida 4155751 33016-1814
Jose Gamez, Site 1140
305-805-0921
Homestead 4159050, Florida 4155751 33030
John Cintron, Site 1229
Homestead 4159050, Florida 4155751 33032
Nelson Gonzalez, Site 1049
786-715-2200
Homestead 4159050, Florida 4155751 33033
Angel Carrasco, Site 1159
786-422-7374
Maitland 4163220, Florida 4155751 32751-5669
Brandon Lenox, Site 1039
407-670-5833
Miami 4164138, Florida 4155751 33122-1335
Emelina Arocha, Site 1021
305-445-5994
Miami 4164138, Florida 4155751 33122-1721
Yanely Pineiro Puebla, Site 1118
786-218-1733
Miami 4164138, Florida 4155751 33133-4231
Francisco Ricart, Site 1108
208-346-8900
Miami 4164138, Florida 4155751 33135-1601
Brian Villa, Site 1125
786-238-7099
Miami 4164138, Florida 4155751 33135-2968
Yordan Orive Gomez, Site 1236
305-223-2000
Miami 4164138, Florida 4155751 33135
Emilio Mantero-Atienza, Site 1115
305-326-0776
Miami 4164138, Florida 4155751 33145-2455
Thierry Jacquemin, Site 1143
305-359-7666
Miami 4164138, Florida 4155751 33155-4630
Michael Pfeffer, Site 1009
866-879-2507
Miami 4164138, Florida 4155751 33155-6630
Cesar Guerrero, Site 1113
786-359-4867
Miami 4164138, Florida 4155751 33165-3947
Pilar Trueba, Site 1129
305-888-0410
Miami 4164138, Florida 4155751 33165
Carlos Ramirez Calderon, Site 1150
786-801-0912
Miami 4164138, Florida 4155751 33173
Maria Nualart, Site 1111
305-263-7120
Miami 4164138, Florida 4155751 33174-2950
Sonia Rente, Site 1109
305-551-8493
Miami 4164138, Florida 4155751 33175
Christopher Jimenez, Site 1158
305-246-0873
Miami 4164138, Florida 4155751 33176-1451
Sergio Jaramillo, Site 1235
305-596-2080
Miami 4164138, Florida 4155751 33176-7947
Leon Ramon, Site 1147
786-600-7005
Miami 4164138, Florida 4155751 33176
Roberto Hernando, Site 1234
305-892-1035
Miami 4164138, Florida 4155751 33179-2537
Gretel Trullenque, Site 1105
786-391-1137
Miami 4164138, Florida 4155751 33184-1412
Jorge Gonzalez, Site 1157
305-392-0244
Miami 4164138, Florida 4155751 33186-4643
Jorge Paoli Bruno, Site 1054
000-000-0000
Miami 4164138, Florida 4155751 33186-5882
Maria Rodil, Site 1042
786-808-0832
Miami Gardens 4164167, Florida 4155751 33056-4000
Marta Fernandez, Site 1126
305-269-7100
Miami Lakes 4164186, Florida 4155751 33014-5602
Nancy Navarro Gonzalez, Site 1032
Miami Lakes 4164186, Florida 4155751 33014-6435
Gonzalo Quesada, Site 1102
305-705-4494
Miami Springs 4164223, Florida 4155751 33166-5260
Antonio Terrelonge, Site 1026
305-885-8983
Orlando 4167147, Florida 4155751 32807-3555
Eric Carbonell, Site 1112
407-440-4493
Ormond Beach 4167178, Florida 4155751 32174-3101
David McDonald, Site 1204
386-673-2500
Sweetwater 4174600, Florida 4155751 33182
Delores Macksoud, Site 1133
786-631-3890
Tampa 4174757, Florida 4155751 33614-2700
Sadaf Bazargan, Site 1124
813-300-3300
Tampa 4174757, Florida 4155751 33614-2869
Al Robaina, Site 1123
813-931-0128
Tampa 4174757, Florida 4155751 33629-5837
Jamie Fernandez, Site 1110
813-251-1800
West Palm Beach 4177887, Florida 4155751 33407-3209
Paul Winner, Site 1216
561-845-0500
Atlanta 4180439, Georgia 4197000 30328-5532
Vasundhara Cheekati, Site 1206
404-382-8660
Flowood 4426822, Mississippi 4436296 39232
Joseph Kwentus, Site 1132
601-420-5810
Toms River 4504476, New Jersey 5101760 08755
Ashok Patel, Site 1232
732-244-2299
Woodmere 5145028, New York 5128638 11598-1739
David Steiner, Site 1025
516-239-1800
Cypress 4684724, Texas 4736286 77429-6070
Harpaul Gill, Site 1106
949-491-0710
Houston 4699066, Texas 4736286 77074-2085
Nelson Berrios, Site 1004
San Juan 4568127, Puerto Rico 00926-3160
Ileana Fumero-Perez, Site 1304
More Details
- NCT ID
- NCT05980949
- Status
- Recruiting
- Sponsor
- Karuna Therapeutics
Study Contact
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com855-907-3286
Clinical.Trials@bms.com